 | Up a level |
La Manna, Federico; Hanhart, Daniel; Kloen, Peter; van Wijnen, Andre J; Thalmann, George; Kruithof-de Julio, Marianna; Chouvardas, Panagiotis (2023). Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union. Gene, 874(147481), p. 147481. Elsevier 10.1016/j.gene.2023.147481
La Manna, Federico; De Menna, Marta; Patel, Nikhil; Karkampouna, Sofia; De Filippo, Maria Rosaria; Klima, Irena; Kloen, Peter; Beimers, Lijkele; Thalmann, George N.; Pelger, Rob C. M.; Jacinto, Estela; Kruithof-de Julio, Marianna (2021). Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Frontiers in oncology, 11, p. 650623. Frontiers Research Foundation 10.3389/fonc.2021.650623
La Manna, Federico; De Menna, Marta; Patel, Nikhil; Karkampouna, Sofia; De Filippo, Maria; Klima, Irena; Kloen, Peter; Beimers, Lijkele; Thalmann, George N.; Pelger, Rob C M; Jacinto, Estela; Kruithof-de Julio, Marianna (2020). Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Frontiers in oncology, 10(1012), p. 1012. Frontiers Research Foundation 10.3389/fonc.2020.01012
Zoni, Eugenio; Astrologo, Letizia; Ng, Kiu Yan Charlotte; Piscuoglio, Salvatore; Melsen, Janine; Grosjean, Joël; Klima, Irena; Chen, Lanpeng; Snaar-Jagalska, Ewa B; Flanagan, Kenneth; van der Pluijm, Gabri; Kloen, Peter; Cecchini, Marco G; Kruithof-de Julio, Marianna; Thalmann, George (2019). Therapeutic targeting of CD146/MCAM reduces bone metastasis in prostate cancer. Molecular cancer research, 17(5), pp. 1049-1062. American Association for Cancer Research AACR 10.1158/1541-7786.MCR-18-1220
Henle, Philipp; Kloen, Peter; Siebenrock, Klaus A (2007). Femoral head injuries: Which treatment strategy can be recommended? Injury - international journal of the care of the injured, 38(4), pp. 478-88. Oxford: Elsevier 10.1016/j.injury.2007.01.023
